Toric Lentis Mplus intraocular lens opacification: A case report.
Calcification
High myopia
Hydrophilic acrylic intraocular lens
Opacification
Journal
American journal of ophthalmology case reports
ISSN: 2451-9936
Titre abrégé: Am J Ophthalmol Case Rep
Pays: United States
ID NLM: 101679941
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
31
07
2019
revised:
10
12
2019
accepted:
14
03
2020
entrez:
16
4
2020
pubmed:
16
4
2020
medline:
16
4
2020
Statut:
epublish
Résumé
To present the case of a patient with Toric Lentis Mplus intraocular lens (IOL) (Oculentis, Berlin, Germany) opacification after vitrectomy and his follow-up. A 44-year-old man with high myopia and right optic neuritis history complained of visual impairment due to cataract in the right eye. We performed uneventful phacoemulsification and implanted a Toric Lentis Mplus IOL in his right eye. Six months later, he came to us with a retinal detachment in the nasal area of the right eye. We performed a 25-gauge vitrectomy with gas tamponade and endolaser treatment. Ten months after the vitrectomy, he complained of blurred vision in the right eye again. On slit-lamp examination, we observed a wide opacification localized to the anterior surface of the IOL. We explanted the IOL from the right eye and replaced it with a Clareon IOL (Alcon, Fort Worth, TX). The explanted IOL was examined under light microscopy and scanning electron microscopy. We described a case of postoperative opacification of Toric Lentis Mplus IOL after vitrectomy. We found calcium aggregate deposits on the anterior surface of the IOL. Given the higher frequency of fundus disease observed in patients with high myopia, hydrophilic acrylic IOLs should be used with caution in patients with high myopia and in young patients. To our knowledge, this is the first report of Toric Lentis Mplus IOL opacification after the 2017 Field Safety Notice by Oculentis in response to the Food and Drug Administration's recall.
Identifiants
pubmed: 32292834
doi: 10.1016/j.ajoc.2020.100672
pii: S2451-9936(20)30046-3
pii: 100672
pmc: PMC7149404
doi:
Types de publication
Case Reports
Langues
eng
Pagination
100672Informations de copyright
© 2020 The Authors.
Références
J Ophthalmic Vis Res. 2009 Apr;4(2):122-4
pubmed: 23198059
J Cataract Refract Surg. 2016 Sep;42(9):1324-1331
pubmed: 27697251
J Cataract Refract Surg. 2015 Jan;41(1):199-207
pubmed: 25465216
Int J Ophthalmol. 2016 May 18;9(5):699-702
pubmed: 27275424
Eur J Ophthalmol. 2010 Nov-Dec;20(6):1082-5
pubmed: 20602329
J Cataract Refract Surg. 2001 Sep;27(9):1485-92
pubmed: 11566535
J Cataract Refract Surg. 2004 Jan;30(1):250-2
pubmed: 14967298
J Cataract Refract Surg. 2018 Nov;44(11):1326-1332
pubmed: 30279087
J Cataract Refract Surg. 1999 Aug;25(8):1109-15
pubmed: 10445197
J Cataract Refract Surg. 2015 Jan;41(1):140-5
pubmed: 25532641
J Cataract Refract Surg. 2010 Aug;36(8):1427-31
pubmed: 20656168
BMJ Open Ophthalmol. 2018 Dec 15;3(1):e000157
pubmed: 30623024
J Cataract Refract Surg. 2002 Jul;28(7):1160-72
pubmed: 12106724
J Cataract Refract Surg. 2010 Apr;36(4):676-81
pubmed: 20362864
J Cataract Refract Surg. 2009 Mar;35(3):451-8
pubmed: 19251137
Am J Ophthalmol. 2012 Jun;153(6):1154-60.e1
pubmed: 22325304
Ophthalmology. 2008 Jan;115(1):73-9
pubmed: 17498804
J Cataract Refract Surg. 2008 Jan;34(1):80-6
pubmed: 18165086